A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma-Reference-Cited by-同舟云学术

A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma

Published:1995-09 Issue:5228 Volume:269 Page:1281-1284
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Wölfel Thomas¹,Hauer Martina¹,Schneider Jörg¹,Serrano Manuel²,Wölfel Catherine¹,Klehmann-Hieb Eva¹,De Plaen Etienne³,Hankeln Thomas⁴,Meyer zum Büschenfelde Karl-Hermann¹,Beach David²

Affiliation:

1. I. Medizinische Klinik und Poliklinik, Johannes Gutenberg-Universität, D-55101 Mainz, Germany.

2. Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.

3. Ludwig Institute for Cancer Research, Université Catholique de Louvain, UCL 7459, B-1200 Brussels, Belgium.

4. Institut für Molekulargenetik, Johannes Gutenberg-Universität, D-55099 Mainz, Germany.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference50 articles.

1. BRASH, D.E., A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 88: 10124 (1991).

2. BRICHARD, V, THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS, JOURNAL OF EXPERIMENTAL MEDICINE 178: 489 (1993).

3. CALDAS, C, FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA, NATURE GENETICS 8: 27 (1994).

4. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

5. COULIE, P.G., A NEW GENE CODING FOR A DIFFERENTIATION ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS, JOURNAL OF EXPERIMENTAL MEDICINE 180: 35 (1994).

Cited by 1019 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Vaccines for Melanoma;Hematology/Oncology Clinics of North America;2024-10

2. CD4 ⁺ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy;Science Immunology;2024-09-13

3. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations;Current Oncology;2024-08-23

4. RNA vaccines for cancer: Principles to practice;Cancer Cell;2024-07

5. Public neoantigens in breast cancer immunotherapy (Review);International Journal of Molecular Medicine;2024-06-17